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Abstract: This systematic review aims to assess the characteristics of, and the clinical and 
economic  evidence  provided  by,  economic  evaluations  of  primary  preventive  physical 
exercise interventions, and to analyse their transferability to Germany using recommended 
checklists.  Fifteen  economic  evaluations  from  seven  different  countries  met  eligibility 
criteria, with seven of the fifteen providing high economic evidence in the special country 
context. Most of the identified studies conclude that the investigated intervention provide 
good  value  for  money  compared  with  alternatives.  However,  this  review  shows  a  high 
variability  of  the  costing  methods  between  the  studies,  which  limits  comparability, 
generalisability and transferability of the results. 
Keywords:  economic  evaluation;  cost-effectiveness;  physical  activity  intervention; 
transferability; cost-utility; primary prevention 
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1. Introduction 
One of the WHO European regional targets for the twenty-first century is that ‘by the year 2015, 
people across society should have adopted healthier patterns of living’ [1]. The WHO target refers to a 
variety of key behavioural factors contributing to the large societal burden of disease, one of them 
being physical inactivity. The global estimate for the prevalence of physical inactivity among adults is 
17% [2]. Overweight and inactivity have been shown to be associated with several risk factors such as 
hypertension, diabetes mellitus type 2 and dyslipoproteinemia [3]. 
Increased physical activity and dietary intervention have been shown to have a preventive effect 
and/or a strong effect on health risks, e.g., effecting a reduction of cardiovascular risk factors [3,4]. 
Many  reviews  and  meta-analyses  confirm  this  positive  correlation  between  physical  activity  and 
psychological, physiological and social effects focussing on secondary prevention [5-12]. Although the 
literature strongly confirms  the effectiveness  of physical activity interventions, translation of these 
findings into public health practice has been limited. There is a need for data on the cost-effectiveness 
of physical exercise intervention programmes to support policy-makers in decisions based on valid 
information about the value of those interventions. 
There exist many reviews of cost-effectiveness of secondary prevention programmes that include 
physical exercise as one treatment option, e.g., [13-17]. Earlier reviews examine economic results of 
primary and secondary preventive physical activity programmes [15,18-20]. Gordon et al. analysed the 
evidence for cost-effectiveness of health behaviour interventions that comprise the major behavioural 
risk factors for chronic diseases including smoking, physical inactivity, poor diet and alcohol abuse. 
The reported incremental  cost-effectiveness  ratios  (ICER) per life  years gained (LYG) range from 
€1,800 to  €47,500, and the costs per quality adjusted life year (QALY) vary between €2,200 and 
€53,500 (2006 Euros) for physical activity interventions. In comparison, ICERs for smoking cessation 
are consistently low, e.g., <€14,000 per LYG. Gordon et al. did not differentiate between primary and 
secondary  prevention  [18].  Hill  et  al.  analysed  the  effect  that  economic  factors  such  as  industry 
practices have on eating and physical behaviours, and Hagberg and Lindholm focussed on different 
aspects of outcomes and equity in health [15,19]. NICE also included secondary prevention in its rapid 
review of the economic evidence, and Shepard examined the economics of fitness with special focus 
on worksite programmes and found an immediate return of CAD2-8 per dollar invested [20,21]. 
Systematic reviews can help making well-informed decisions on which intervention to adopt for a 
particular country or region. For maximum usefulness, cost-effectiveness studies should be transparent, 
of high methodological quality and high economic evidence. The aim of this systematic review is to 
analyse  the  clinical  and  economic  evidence  in  the specific country context  provided by economic 
evaluations of primary preventive physical activity programmes, and to discuss the transferability of 
the findings of these studies to Germany. 
2. Methods 
2.1. Search Process 
In  order  to  identify  all  relevant  studies  published  before  December  2009,  the  database 
PubMed/Medline was searched for all possible combinations out of three groups of terms. The first Int. J. Environ. Res. Public Health 2010, 7                 
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group included different terms assigned to physical activity, such as ‘Movement’ OR ‘Exercise’ OR 
‘Exercise  Therapy’  OR  ‘Exercise  Test’  OR  ‘Exercise  Movement  Techniques’  OR  ‘Exercise 
Tolerance’. The second group broadly described different methods of economic evaluation: ‘Costs and 
Cost  Analysis’ OR  ‘Economics’. The third group contained terms for prevention: ‘Prevention and 
Control’ OR ‘Primary Prevention’ OR ‘Accident Prevention’ OR ‘Health Promotion’ OR ‘Centres for 
Disease Control and Prevention (U.S.)’. Most of the selected MeSH-terms are generic terms, each 
encompassing  a  set  of  subordinate  search  words.  Thus,  for  example,  the  search  for  ‘Cost-Benefit 
Analysis’ is covered by the search for ‘Costs and Cost Analysis’ [MeSH]. Similarly, ‘motor/physical 
activity’ is assigned to the MeSH-term ‘movement’. Additional searches on the DIMDI, EconLit and 
Embase  databases  were  carried  out  analogously.  Based  on  assessments  of  the  abstracts,  a  list  of 
relevant  papers  was  derived.  Papers  were  deemed  potentially  relevant  if  outcomes  and  costs  of  a 
primary prevention physical activity programme were evaluated. 
2.2. Inclusion and Exclusion Criteria 
Only studies published in peer-reviewed scientific journals in English, Dutch, French and German 
language before December 2009 were selected for this review. This review is limited to trial-based 
economic evaluations of primary prevention programmes focussing on an adult population. This type 
of study with strong and convincing evidence for efficacy is of high priority to the German Institute for 
Quality and Efficiency in Health Care (IQWiG) [22]. Therefore, studies that were based on secondary 
research, literature-based modelling and literature reviews were excluded. Reported findings were not 
included if they were anecdotal and/or not evaluated. The present review is limited to full economic 
evaluations  (primarily  cost-effectiveness,  cost-utility  and  cost-benefit  analyses)  that  report  the  
cost-effectiveness of primary prevention programmes based on physical exercise. 
2.3. Data Extraction and Criteria 
In total, 944 studies were identified from the first search in PubMed, including all studies that were 
completed  before  December  2009.  Many  of  these  were  secondary  prevention  studies,  observation 
studies, or studies that covered only effectiveness. Others were reviews, focussed on children or were 
not peer-reviewed, and, thus, were excluded from further examination. On the basis of the title, 375 
papers were considered as relevant for the review and were obtained in abstract. One hundred and one 
abstracts were excluded, the remaining 274 articles were examined with regard to the inclusion and 
exclusion criteria. In total, 15 of the finally selected primary research studies described an economic 
evaluation of primary preventive physical activity programmes for adults. Additional searches in the 
DIMDI,  EconLit  and  Embase  databases  showed  no  further  relevant  results.  Following  the 
recommendations of Moher et al. Figure 1 (Appendix) describes the flow of information through the 
different phases of the systematic review [23]. Data extraction and assessment were undertaken and 
checked by two researchers. Int. J. Environ. Res. Public Health 2010, 7                 
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2.4. Study Characteristics and Key Findings 
All 15 studies were briefly described by means of important characterising aspects, including ‘type 
of  physical  exercise  intervention/alternative/length  of  intervention,  outcomes,  study  population, 
country/setting/year(s) of the study, study design/type of economic evaluation, economic key findings 
and clinical/economic evidence’ (Table 1). In addition to presenting the key findings in their local 
currency and price year, costs were converted to Euros using purchasing power parities (PPP) [24] in 
order to facilitate comparisons across studies. These results were then inflated to 2008 prices using 
general price indices (GDP) [25]. If information on the base year for prices was missing, the year of the 
intervention was used instead, if indicated. 
2.5. Clinical and Economic Evidence 
The  level  of  evidence  regarding  the  effectiveness  of  the  intervention  was  evaluated  using  the 
evidence gradients developed in evidence-based medicine [22,26-28]. Therefore, all selected studies 
were assessed against relevant criteria such as randomisation, blinding and concealment of allocation, 
comparability of the groups, description of the drop-out rate or compliance/participation rate and the 
intention-to-treat approach [28-30]. 
Different  internationally  recommended  guidelines  for  economic  evidence  of  trials  already  
exist  [28,31-34].  The  CHEC-list  (Consensus  on  Health  Economic  Criteria)  by  Evers  and  
colleagues [32], which is based on expert consensus of 23 international experts in a DELPHI-panel, 
seemed to be most suitable for this review. Each criterion has to give insight into the quality of the 
study performed, rather than into how the study is performed. The CHEC-list is suitable for systematic 
reviews, which include full economic evaluations based on clinical trials, e.g., case-control studies, 
cohort studies or randomised controlled clinical trials, which compare two or more alternatives, and in 
which  both  costs  and  outcomes  of  alternatives  are  determined  aimed  at  more  transparency  and 
comparability  [32].  The  CHEC-list  provides  19  yes-or-no  questions,  one  for  each  criterion  of 
evaluation. If the information pertinent to the question is not available in the reviewed article, the 
assessor ticks it with ‘no’; if the question has been fully answered in the article, the statement would be 
‘yes’. In this review, the CHEC-list is applied in a modified manner. When a criterion in an article 
could be identified but not fully answered, the evaluation was 0.5. The statement ‘no’ was valued with 
0 and ‘yes’ with  1. An overview of the detailed evaluation of the economic evidence against the 
CHEC-list can be found in Table 2 in the appendix. 
2.6. Transferability 
A prerequisite for examining the transferability of international studies to Germany requires that 
methods, data resources and study results are transparently and comprehensible described [22,26,35]. 
Welte  et  al.  systematically  identified  the  factors  that  may  influence  the  transferability  of  health 
economic study results between countries. These transferability factors can be differentiated into three 
categories:  methodological  characteristics  (perspective,  discount  rate,  medical  cost  approach, 
productivity cost approach), healthcare system characteristics (absolute and relative prices in health 
care,  practice  variation,  technology  availability)  and  population  characteristics  (disease  incidence/ Int. J. Environ. Res. Public Health 2010, 7                 
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prevalence, case-mix, life expectancy, health status preferences, acceptance, compliance, incentives to 
patients, productivity and work-loss time, and disease spread). All potential transferability factors have 
to possess four characteristics: influence on outcomes of economic evaluations, international variation, 
measurability and being distinguishable from other factors [35]. Aspects of the transferability of the 
identified studies are discussed in detail. 
3. Results 
3.1. Study Characteristics and Key Findings 
Altogether, 15 economic evaluations of physical activity programmes in primary prevention were 
identified. All were published in English between the years 1992 and 2008. The study characteristics of 
all economic evaluations, including keyfindings and methodological issues can be found in Table 1. 
The  type  of  physical  exercise  programme  varied  strongly,  e.g.,  a  group-based  community 
programme  or  an  individually  supervised  fitness  programme.  Personal  supervised  or  written 
unsupervised advice via email, postal way or telephone calls was provided.  
The adult study populations of the reviewed interventions ranged over different age groups and 
characteristics, including, e.g., employees, patients of general practitioners or uninsured women with 
low income. The interventions included a range of targets (e.g., from moderate to high impact exercise) 
and delivery methods (e.g., general practitioner, health professional advice, home–based programmes 
led by nurses or physiotherapists). 
The optimal time horizon of an intervention depends on the evaluation of all outcomes, i.e., the time 
horizon is not long enough if outcomes ensue after the evaluation period. The length of the reviewed 
interventions ranged from 10 weeks to 12 years. The follow-up time in the studies reviewed ranged 
from no follow-up to as long as 12 years [36,37].  
The outcomes were selected according to the respective study aim and therefore varied from specific 
measures,  e.g.,  activity  change,  work  participation  or  deleterious  health  events  (falls)  to  generic 
measures, like QALYs or DALYs. Outcomes were valued and calculated with different scores and 
indexes derived from literature or statistics, e.g., the health state utility index by Brazier [38,39] or a 10 
year CVD risk score for angina pectoris, myocardial infarction, heart failure or CVD mortality [40].  
Regarding the clinical effectiveness, the reviewed interventions were significantly more effective 
than alternative interventions or usual care in twelve studies, including increase in total expenditure of 
energy [38,41,42], in quality of life [36-39,43,44], in DALYs [45], in VO2(max) [46,47] and reduction 
in falls [48-50]. No significant differences were measured in lower absenteeism rates, less healthcare 
claim reimbursement [37], decrease in 10 year probability of CHD [40], positive changes in mortality 
rate,  survival  times,  or  admissions  to  hospital  [39]  and  an  increase  of  occasions  of  physical  
activity [42]. High-level intervention is marginally more effective in improving diet, physical fitness 
and blood cholesterol [37,51]. 
The authors of the analysed studies used different types of economic evaluations influencing the 
economic  key  findings  presented.  Twelve  of  the  identified  studies  performed  a  cost-effectiveness 
analysis.  The  cost-effectiveness  studies  of  Robertson  et  al.  were  all  included,  even  though  they 
assessed three similar home-based programmes for elderly people aimed to prevent falls. Age and sex Int. J. Environ. Res. Public Health 2010, 7                 
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of the target populations differed between the studies as well as the delivery of the exercise programme 
(by district nurse, general practice nurse or physiotherapist). The results show that the costs per fall 
prevented are lowest in the study including women over 80 years trained by physiotherapists (NZD314/ 
€261 after one year and NZD265/ €220 after two years) [48] compared with mixed study populations 
aged over 80 years (NZD1,519/ €1,202) trained by a general practice nurse [49] and a study population 
aged over 75 years (NZD1,803/ €1,423) trained by a district nurse [50]. 
The healthcare cost savings due to an employee fitness programme are calculated to be around 
NZD1,756  (€1,268)  [38]  per  person  converted  from  a  sedentary  lifestyle  to  an  active  state.  As 
compared with the costs of AUD69 (€62) per patient to become more active, calculated by Sims et al., 
this result seems rather high [45]. Elley and colleagues only implemented a cost-effectiveness analysis, 
even though they assessed the parameters of the SF-36, a QALY index instrument [38]. The results of 
these outcomes  were not  used for a cost-utility analysis. Two studies  reported net  savings  due to 
physical intervention [37,41]. 
Shepard  and  colleagues  conducted  cost-effectiveness  and  cost-benefit  analyses  of  the  10  year 
follow-up of an employee fitness and lifestyle programme [37]. They calculated a return on investment 
of CAD6.85 (€7.64) over 12 years. Prior studies on this programme were excluded from this analysis 
because  of  an  incomplete  economic  evaluation  method  [52,53].  The  worksite  physical  activity 
counselling  programme  analysed  by  Proper  et  al.  resulted  in  total  net  costs  of  €305  during  the 
intervention,  but  €635  benefits  from  sick  leave  reduction  after  one  year  in  favour  of  the  
intervention [41]. In comparison, programme benefits per worker per year of another employee fitness 
programme were estimated to be CAD679 (€757) [37]. 
Four of the identified studies performed a cost-utility analysis based on QALYs [36,39,43,44]. The 
incremental cost per QALY varies between NZD 2,053 (€1,483) [44] and €18,363 [39]. Sims et al. 
calculate a rate of AUD3,647 (€3,258) per DALY saved for the delivery of effective advice on physical 
activity by GPs to patients [45]. The results of the analysed studies are difficult to compare, first due to 
the differences  of the physical  activity programmes and their aims, second due to methodological 
differences especially the high variation of outcomes and third, the lack of transparency of the methods 
and data used. Table 1 provides an overview of all economic key findings. 
 
3.2. Clinical and Economic Evidence in the Special Country Context 
The evidence regarding the effectiveness of an intervention depends on the study design and the 
bias,  which  can  influence results  of a study because of a systematic error, deviation  in  results  or 
inferences from the truth [22,26-28]. The level of evidence on effectiveness depends on the study 
design,  with  the  highest  ranking  given  to  randomised  clinical  trials,  which  were  conducted  in  13 
studies. Only two studies conducted a controlled trial without randomisation [37,49]. 
It is unclear whether the studies incorporated blind or concealed trials. An intention-to-treat analysis 
was  conducted  in  seven  studies  [38,42,46,48-51].  All  studies,  at  least  briefly,  mentioned  the 
compliance and participation rates of their study populations. Int. J. Environ. Res. Public Health 2010, 7                 
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Table 1. Study characteristics and key findings. 
Author (year 
published) 
[Ref.] 
Study 
design/ 
Type of 
EconA 
Type of physical exercise 
intervention/alternative/length 
of intervention 
Outcomes 
Study Population: n/age (range or 
mean)/exclusion and/or inclusion 
criteria 
Country/ 
setting/year of 
study 
Economic key findings  
EURO 
conversion 
(2008) 
Clin.*/ 
econ. 
evidence 
(h, l, 
m)** 
Dzator et al. 
(2004) [51] 
RCT/ 
CEA 
Self-directed intervention of 
PA and nutrition delivered by 
mail (low level) or by mail and 
group sessions (high level)/no 
intervention/16 weeks 
Change in BMI, total 
and HDL cholesterol, 
blood pressure, PA 
(W/kg), nutrition fat 
intake  
137 couples/all ages/IN: 
cohabitation for the first time, 
living together for < 2 years, no 
pregnancy for length of study/EX: 
CHD, severe asthma, diabetes 
Australia/ 
home/ n.s. 
1-year follow up: Average incremental 
costs/unit change in outcome variables: 
1) high intervention: AUD460; 2) low 
intervention: AUD459; 3) control: AUD462 
No year of 
intervention 
1+/m 
Elley et al. 
(2004) [38] 
Cluster 
RCT/ 
CEA 
Green Prescription: verbal and 
written exercise advice by GP 
and telephone exercise 
specialist/usual care/1 year 
Total energy 
expended (change in 
PA), QALY 
878/40-79 years/IN: less active 
(<2.5 hours of moderate activity 
per week) 
New Zealand/ 
GPP/ 
2000-2002  
1) Monthly CER: NZD11/kcal/kg/day; 
2) ICER: NZD1,756/ converted sedentary 
adult to an active state in 12 months 
1) €8; 
2) €1,268  
1-/h 
Finkelstein et 
al. (2002) [40] 
RCT/ 
CEA 
WISEWOMAN Project: 
screening and counselling (e.g., 
walking, dance, chair-aerobics, 
weight training)/MI vs. EI/1 
year 
Risk of CHD, LYG  1586 women/40-64 years/IN: 
uninsured or underinsured with 
low annual income/take part in 
NBCCED-programme  
USA/ 
community 
and 
healthcare 
sites/1996 
1) IC of EI per person: USD191;  
2) ICER: USD637/ 1%point additional 
decrease in 10 year probability of CHD for 
EI compared with MI; 3) nearly USD5,000/ 
LYG (n.sig.) 
Apy (1996): 
1) €226;  
2) ICER: 
€753; 
3) €5,911  
1-/m 
Robertson et 
al. (2001a) 
[50] 
RCT/ 
CEA 
Otago: Individually home-
based PA by district nurse/ 
usual care/1 year 
Falls and injuries  240/≥75 years/invited by GP/EX: 
abasia, receiving physiotherapy 
New Zealand/ 
GPP/ 1998 
1) ICER: NZD1,803/ fall prevented; 2) 
NZD7,471/ injurious fall prevented (cost 
saving for people older than 80 years) 
1) €1,423; 
2) €5,898 
1+/h  
Robertson et 
al. (2001b) 
[49] 
CT/ 
CEA 
Otago: Individually home-
based PA by general practice 
nurse/usual care/1 year 
Falls and injuries  450/≥80 years/invited by GP/EX: 
abasia, receiving physiotherapy 
New Zealand/ 
GPP/ 1998 
1) ICER: NZD1,519/ fall prevented; 
2) NZD3,404/ injurious fall prevented  
1) €1,202; 
2) €2,694; 
2+/h  
Robertson et 
al. (2001c) 
[48] 
RCT/ 
CEA 
Otago: Individually home-
based PA by physio-
therapist/usual care/2 years 
Falls and injuries  233 women/≥80 years/invited by 
GP/EX: abasia, receiving 
physiotherapy  
New Zealand/ 
GPP, home/ 
1995-1997 
1) ICER: NZD314/ fall prevented (1 year); 
NZD265/ fall prevented (2 years) 
2) NZD457/ injurious fall prevented (1year); 
NZD 426/ injurious fall prevented (2 years) 
1) €261; 
€220 
2) €379; 
€353 
1+/h 
Stevens et al. 
(1998) [42] 
RCT/ 
CEA 
Individual PA by exercise 
development officer/ EI vs 
MI/10 weeks 
PA, number of 
sedentary people  
714 participants/45-74 years/four 
subgroups (sedentary, low/high 
intermediate, active)/2 GPP/EX: 
disabled, CHD 
UK/GPP/n.s.  1) ₤623/ one sedentary person doing more 
PA; 2) ₤2,498/ moving someone who is 
active but below min level 
No year of 
intervention 
1+/m 
The Writing 
Group (2001) 
[47] 
RCT/ 
costs, 
effects 
(CEA) 
PA counselling with current 
recommended care/usual care/2 
years 
Cardio-respiratory 
fitness, self-reported 
PA 
874/35-75 years/IN: inactive, in 
primary care, in stable health, 
EX: chronic diseases, CHD 
USA/GPP/ 
1995-1997 
1) For 2 years: IC/ participant of assistance 
intervention: USD500; 2) IC of counselling 
intervention/ participant: USD1,100 
Apy (1996): 
1) €591; 
2) €1,300 
1++/l 
Proper et al. 
(2004) [41] 
RCT/ 
CBA, 
CEA 
Worksite PA counselling/EI vs. 
MI/9 months 
Sick leave, PA, 
cardiovascular fitness 
299/44 years/IN: civil servants 
from three municipal services, 
performing office work at least 24 
hours a week 
Netherlands/ 
municipal 
services/ 
2000-2001 
CER without (with) imputation of effect 
data: 1) €5 (€3)/ extra energy expenditure 
(kcal/day); 2) €235 (€46)/ beat per minute of 
decrease in submaximale heart rate; 3) total 
net costs (9 months): €305; 4) benefits from 
sick leave reduction (1 year later): €635 
Apy (2000):  
1) €6 (€3); 
2) €267 
(€52); 
3) €346; 
4) €721 
1+/m  Int. J. Environ. Res. Public Health 2010, 7                 
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Table 1. Cont. 
Shepard 
(1992) [37] 
CT/ 
CBA, 
CEA 
Employee fitness programme 
(rhythmic, aerobic type 
activity, stretching, cardio-
respiratory activity)/no 
intervention/12 years 
PA, absenteeism, 
corporate 
commitment 
534/age n.s./office workers of 
two major insurance 
companies 
Canada/ 
company/ 
1977-1990 
1) Programme benefits/worker/year 
(participation rate of 20%): CAD679;  
2) ROI: CAD7;  
3) Cost-benefit: CAD5 to 1 
1) €757; 
2) €8;  
3) €5 to 1 
2-/l 
Chen et al. 
(2008) [36] 
Cluster 
RCT/CUA 
Walking/no intervention/12 
weeks 
Health service 
utilisation, QALY  
98/>65 years  Taiwan/ 
community/ 
n.s. 
ICER: USD15,103/ QALY gained  No year of 
intervention 
1-/m 
Dalziel/ Segal 
(2006) [44] 
Cluster 
RCT/ 
CUA 
(Markov 
Model) 
Green Prescription: verbal and 
written exercise advice by GP 
and telephone exercise 
specialist/usual care/1 year 
Lifestyle change, 
activity change, 
QALYs 
878/40-79 years/42 GPP/IN: 
less active  
New Zealand/ 
GPP/ 
2000-2002 
ICER: NZD2,053/ QALY gained (lifetime)  €1,483  1-/m 
Lindgren et 
al. (2003) 
[43] 
RCT/ 
CEA, 
CUA 
(Markov 
Model) 
Dietary advice by dietician and 
exercise instructions by 
physician/usual care/18 
months 
Physiological 
factors, QALYs, 
LYG 
813 men/60 years/EX: CHD, 
diabetes, severe illness, no 
cholesterol, regular use of 
drugs 
Sweden/ 
community/ 
1992 
ICER (declining effect of intervention):  
1) Diet: SEK127,065/ LYG (SEK130,505/ 
QALY gained); 2) Exercise: SEK180,470/ 
LYG (SEK191,750/ QALY gained);  
3) Exercise+diet: SEK201,375/ LYG 
(SEK201,375/ QALY gained)  
1) €15,274 
(€15,687); 
2) €21,693 
(€23,049); 
3) €24,206 
(€24,206) 
1+/h  
Munro et al. 
(2004) [39] 
Cluster 
RCT/ 
CUA 
Free exercise classes (e.g., 
bowling, swimming, country 
walking, and tea dances) by 
qualified exercise leader/usual 
care/2 years 
Mortality, hospital 
service use, health 
status, QALY 
6420/>65 years/EX: PA score 
in the top 20%, patients who 
were unsuitable for exercise  
UK/ 
community/ 
2003-2004 
ICER: €17,172/ QALY gained  ICER: 
€18,364 
1-/h 
Sims et al. 
(2004) [45] 
Cluster 
RCT/ 
 CEA, 
CUA 
(Model) 
Active Script Programme 
(ASP): training and support of 
GPs who deliver advice on 
PA/usual care/2 years 
Number of 
advising GPs, 
patients becoming 
active or accruing 
health benefit, 
DALYs/ deaths 
averted 
670 GPs/practice 
population/20-75 years, 
sedentary 
Australia/ 
GPP/ 
community/ 
1999-2000, 
2000-2001 
1) AUD69/ patient to become more active 
(short term); 2) AUD138/ patient to accrue a 
health benefit; 3) AUD3,647/ DALY saved;  
4) AUD48,924/ premature death averted 
1) €62;  
2) €123;  
3) €3,258;  
4) €48,708 
1-/h 
* (1++) High quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias; (1+) High quality meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias; (1-) 
High quality meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias; (2+) Well-conducted case-control, before-after studies or cohort studies with a low risk of confounding, bias or 
change and a moderate probability that the relationship is causal. (2-) Case-control, before-after studies or cohort studies with a high risk of confounding, bias or change and a high risk that the relationship 
is not causal. [28] ** h = high; l = low; m = moderate. Abbreviations: ASP: Active Script Programme; apy: Assumed price year; BMI: Body-mass-index; CHD: Cardiovascular heart disease; CG: Control 
Group; CT: Controlled trial; CBA: Cost benefit analysis; CE: Cost-effectiveness; CEA: Cost-effectiveness analysis; CER: Cost-effectiveness ratio; CUA: Cost utility analysis; DALY: Disability adjusted life 
years; EconA: Economic analysis; EI: Enhanced intervention; EX: Exclusion criteria; GP: General practitioner; GPP: General practitioner practices; HDL: High Density Lipoprotein; IN: Inclusion criteria; 
ICER: Incremental cost-effectiveness ratio; IG: Intervention Group; kcal: Kilocalorie; LYG: Life years gained; MI: Minimum intervention; NBCCED: National Breast and Cervical Cancer Early Detection; 
NB: Net benefit; n.s.: not stated; PA: Physical activity; QALY: Quality adjusted life year; RCT: Randomised controlled trial; ROI: Return on investment; SEK: Swedish Krona; W/kg: Watt/kilogram.Int. J. Environ. Res. Public Health 2010, 7                 
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A potential selection bias in physical exercise programmes cannot be fully excluded, e.g., whether 
the control group also takes part or only the motivated people take part in the exercise trial as in the 
study by Elley et al. [38]. Dzator et al. stated over-representation of higher economic status in their 
study  population  [51],  and  Munro  excluded  those  with  a  physical  activity  score  in  the  top  20% 
assuming little gain  from  additional exercise there  [39]. Stevens et al. discussed the limitation of 
quality and transferability of their results because of the possibility of an instructor bias [42]. The 
results of three other physical exercise programmes for older people by Robertson et al. were possibly 
influenced by an instructor bias, e.g., by one motivated research physiotherapist [48] or by an educated 
district or general practice nurse [49,50]. Finkelstein et al. did not discuss the baseline comparability of 
the two intervention groups [40]. Overall, seven RCTs had a low or very low risk of bias, showing high 
clinical evidence [41-43,47,48,50,51], and six RCTs had a high risk of bias, thus moderate clinical  
evidence [36,38-40,44,45]. There were only two case-control studies, one with a low [49] and one with 
a high risk of bias [37]. 
Next to the clinical evidence, the economic evidence in the special country context is important for 
decision-makers.  In  the  following,  the  main  methodological  weaknesses  affecting  the  level  of 
economic  evidence  will  be  summarised  for  each  study.  The  detailed  evaluation  of  the  economic 
evidence and factors affecting this evaluation are presented in the Appendix, Table 2. 
The three studies by Robertson et al. are of high economic evidence. They included implementation 
costs  as  well  as  overhead  costs  of  each  hospital  item  and  excluded  the  government  goods  and 
consumption taxes [48-50]. However, ethical and distributional issues are not discussed appropriately; 
these were only commented on in three studies [36,37,40]. The missing discount rate in one study with 
a 2 year time horizon should have been discussed, but the impact on the results would have been  
rather small.  
The economic evidence of the three identified lifetime models is medium to high, but the methods 
applied  for  measurement  and  valuation  of  costs  should  be  described  in  more  detail  [43-45].  
Dalziel et al. used a health system perspective only and a model based on many assumptions [44]. The 
methods  of  discounting,  as  well  as  the  modelling  approach,  were  not  clearly  described  by  
Sims et al. [45]. 
The two cost-utility analyses included are of moderate to high economic evidence. However, the 
time horizon of the intervention by Chen et al. was 12 weeks and only programme costs were assessed, 
whereas healthcare utilisation was not monetised. In addition, the cost measurement in physical units 
was not clearly described and the sensitivity of the results to changes in uncertain values was not 
analysed  [36].  Furthermore,  the  perspective  was  not  clearly  stated.  Similar  to  Robertson  et  al.,  
Munro et al. did not discount costs and effects in a 2 year intervention; moreover, they used a health 
service perspective only [39]. The economic evidence of the study by Dzator et al. is limited due to the 
short time horizon of the intervention; none of the perspective, the physical units for cost calculation or 
the year of intervention were stated clearly [51]. The analysis by Elley et al. has only minor economic 
limitations, and, therefore, a high economic evidence. However, only the costs were discounted. The 
study by Finkelstein et al. has different limitations, as there was no sensitivity analysis calculated, and 
the perspective, the unit costs and the price year were not mentioned. Moreover, only effects were 
discounted [40]. Proper et al. conducted an economic evaluation of moderate economic evidence, as 
the price year and physical units were not stated. Additionally, the time horizon of the intervention Int. J. Environ. Res. Public Health 2010, 7                 
 
 
1631 
including the follow-up was only 9 months and costs were calculated from a municipal service rather 
than a societal perspective [41]. Although the study of Shepard et al. has the longest time horizon of 12 
years,  the  economic  evidence  is  rather  limited,  as  the  physical  unit  costs,  study  years,  ICER  and 
perspective were not explicitly stated. Moreover, there was no sensitivity analysis and future costs and 
outcomes were not discounted [37]. The cost-effectiveness analysis of Stevens et al. was categorised as 
moderate economic evidence. The perspective, the physical units, ICER and year of intervention were 
not  mentioned.  Furthermore,  the  valuation  of  costs  and  some  relevant  cost  components  were  not 
reported [42]. According to the criteria of economic evidence stated above, the study of the Writing 
Group showed the highest limitations. The focus was on reporting of the effects of the intervention, 
whereas  the  economic  methodology  of the ICER  calculation was  not  described. Also,  there is  no 
indication for discounting of future costs and effects [47]. 
The  most  important  methodological  issues  are  summarised  in  the  following.  In  general,  the 
collection of costs depends on the chosen perspective. As far as the perspective of the study was stated, 
it varied between the healthcare payer’s perspective [38,39,43-45], the company’s viewpoint [41] and 
the recommended societal perspective [38,43,48-50]. The methodological quality of costing varied 
among the studies; five of the 15 studies identified valued the costs appropriately. For a complete 
economic evaluation not only programme costs, but also cost savings due to the health effect of the 
programme, are of special importance. Savings include direct medical costs, direct non-medical costs 
and indirect costs due to utilisation of healthcare services. Indirect costs induced by productivity losses 
will only be included if a societal or company perspective is chosen. 
The cost data collection depends on the study type. All direct medical costs were assessed either by 
questionnaire [41], statistical indices [38,39,41], healthcare insurance administration records [37,39,50], 
postcard calendars [48-50] and/or by telephone [48,50]. The valuation of resource consumption varied 
between market prices and charges. Except for Robertson et al. [48-50], all other economic evaluations 
did not mention overhead costs or the valuation of the costs. All costs were declared in their own 
country’s currency. 
A separate and transparent presentation of how the quantities of resource use were determined was 
found in only five of the 15 studies [38,39,48-50]. An incremental analysis was performed in 13 of the 
15 studies. Outcomes were identified, measured and valued appropriately in 13 of the 15 studies. The 
practice of discounting in economic evaluations of healthcare interventions was analysed by Smith and 
Gravelle. The authors recommended the need for discounting if the evaluation takes more than 18 
months [54]. Regarding the studies with a longer time horizon, only the three model-based evaluations 
included discounts  [43-45]. Hence, the valuation  of the reviewed studies without discounting was 
calculated as 1 if the evaluation period was less than 18 months and 0 if the time horizon was more 
than 18 months. A broad range of important but uncertain variables was investigated in sensitivity 
analyses in 13 of the 15 studies, e.g., completion rates of participants [51], session fee of exercise 
leaders, number of attendees per session or different approaches to calculating costs per QALY [39]. 
In summary, seven studies fulfilled high standards of methodological quality, with more than 80% 
of quality items meeting the criteria [38,39,43,45,48-50]. Six economic evaluations were of moderate 
quality, with 51-80% of quality items meeting the criteria [36,40-42,44,51]. Two studies demonstrated 
poor quality standards, fulfilling only 50% or less of the quality criteria assessed [37,47]. Int. J. Environ. Res. Public Health 2010, 7                 
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3.3. Transferability 
Transferability can be interpreted in a national context in terms of transferability of the results to 
another region or setting, or in an international context. Geographic transferability of the results of 
economic evaluations of physical activity programmes from one country to another has the potential to 
make a more efficient use of national and international evaluations because the implementation of 
primary  clinical  trials  is  very  expensive  and  time-consuming.  However,  inappropriate  transfer  of 
economic  data  can  provide  misleading  results  and  can  lead  to  an  inefficient  use  of  scarce  
health resources. 
Before the transferability to the German context can be examined, three questions must be answered 
positively.  First:  Is  the  considered  technology  comparable  with  a  technology  used  in  Germany? 
Second: Is the comparable intervention relevant for Germany? And third: Is the quality of the study 
acceptable for Germany, and does it fulfil international methodological standards? Transferability of 
the intervention is not given if one question is answered with ‘no’ [22]. The considered technology 
here, different types of physical activity interventions, is comparable with German physical activity 
programmes and is also relevant for the German context, because of a high prevalence of physical 
inactivity. Therefore, the first two questions can be answered with ‘yes’. However, it is not apparent 
whether German companies are comparable with American or Canadian companies and their employee 
fitness activities and fitness centres [37,41]. But the need for health promotion and physical activity 
interventions for sedentary people has also been stated in Germany [55,56]. The third question can also 
be answered in the affirmative, even if the clinical and economic evidence provided by the studies 
varies (Table 1). 
Assessing the transferability of economic evaluation results of physical activity programmes is a 
complex and difficult task. The transferability of the identified studies will be discussed according to 
the checklist of Welte et al. [35]. The criteria of transferability are partly similar to the criteria of high 
economic evidence discussed above. To avoid overlapping, only those transferability criteria that differ 
from the ones above will be discussed in detail in the following section. 
The  methodological  characteristics  include  the  perspective,  the  discount  rate,  the  medical  cost 
approach and the productivity cost approach. The perspective of a considered study is very important in 
terms of transferability to the German healthcare context. The IQWiG proposes the perspective of the 
statutory  health  insurance;  this  proposal  is  controversial  [22,26].  The  societal  perspective  is  more 
accepted and preferred [57]. First, sectors other than the health service may incur costs or benefits as a 
result of healthcare interventions and the societal perspective can help detect cost
 shifting between 
sectors. Second, a narrow perspective takes no account of alternative uses of resources outside the 
healthcare sector, which may
 yield greater welfare to society. The concept of opportunity cost
 reflects 
this broad concern for society’s total welfare [58,59]. Therefore, with respect to the perspective chosen, 
six studies can be considered as being transferable [38,48-50]. 
The  Hanover  Consensus  has  proposed  a  discount  rate  of  5%  for  outcomes  and  costs  for  
Germany  [57].  Only  three  studies  used  a  discount  rate  of  5%  [38,44,51],  and  three  studies  used  
3% [40,43,45]. 
The medical cost approach implies different costing methods for direct medical costs. They can be 
calculated with charges, fees, per diem costs and real market prices, as well as different levels of Int. J. Environ. Res. Public Health 2010, 7                 
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aggregation of resources. Overhead and capital costs, which can be measured in different ways, may be 
included  [60].  The  price  year  is  important  in  terms  of  transferability,  as  well  as  detailed  cost 
measurement and valuation. Charges and fees, such as costs of a general practitioner visit depend on 
the type of healthcare system and the healthcare provider. For costing of healthcare services most of 
the studies used official charges, like Elley et al. [38,39,50]. 
Some studies valued units with fair market prices in the currency of their individual country in the 
year of assessment, e.g., Robertson 2001 [37,39-41,48-50]. Other studies valued their units of resource 
use by actual prices [51], used the consumer price index in the observation period [38] or did not 
explain their proceeding sufficiently, e.g., Shephard 1992 [37,42,47]. If the valuation of costs is not 
described in detail, the possibility of examining the transferability of results is very limited. 
Due to missing information on the price year of adjustment, the transferability of the results of six 
studies is very limited [36,40-42,47,51]. 
Average labour costs or wages, the average productivity and the friction time can differ between 
countries.  The  average  productivity  is  affected  by  parameters  like  labour  force  participation  rate, 
unemployment rate and percentage of part-time workers. The friction method is used for calculating 
the  indirect  costs,  and  the  length  of  the  friction  time  can  strongly  influence the productivity cost 
estimate [35].  Three  of  the  reviewed  studies  include  indirect  costs  due  to  productivity  
losses [38,41,43]. Transferability of the indirect costs according to the study of Proper et al. is not 
possible because there was no assignment of physical units or price year of the follow-up period [41]. 
The study results of Elley et al. can be transferred with constraints because the average stoppage days 
in New Zealand were 1.9 days per employer in the year 2005 [38,61], whereas in Germany the average 
days of sick leave were stated as 10.4 [62,63]. For the calculation of indirect costs, the humancapital 
approach is the standard approach in most countries, except for the Netherlands where the friction cost 
method is proposed [64-66]. Two studies calculated the indirect costs based on sick leave days, leading 
to comparable results between the humancapital and the friction cost method [38,41]. Lindgren et al. 
included the indirect costs related to loss of production due to disease and costs in added years of life 
based on Swedish literature [43]. Even if the Swedish and German data were very different, parts of 
the model could easily be substituted by German data. Robertson et al. did not calculate the indirect 
costs because the target group was retired [48-50]. 
Concerning healthcare system characteristics, the most relevant factors are absolute and relative 
prices  in  healthcare,  practice  variation  and  technology  availability  [35].  Technology  availability 
depends  on  the  country-specific  healthcare  system.  The  reviewed  studies  were  conducted  in  the 
Netherlands, the United States (US), Australia, New Zealand, the United Kingdom (UK), Taiwan, 
Sweden  and  Canada.  Compared  with  Germany,  these  countries  have  rather  different  healthcare 
systems, including market structure and regulation, staff characteristics and effects of learning, and 
incentives  to  healthcare  providers  [67].  WHO  recommends  that  high  priority  should  be  given  to 
national  policies  in  order  to  influence  patterns  of  physical  activity  for  an  effective  prevention  of  
non-communicable  diseases.  Such  policies  should  encompass  broad  measures  involving  different 
sectors  such  as  health,  agriculture,  education,  transportation,  sport,  industry,  commerce  and  civil 
society  [68].  The  contribution-funded  German  healthcare  system,  separated  into  public  health 
insurance and private insurance, shows limited similarities to the healthcare systems of the Netherlands 
and of Canada [37,41]. The results of the other studies, e.g., UK [39,42] or US [40,47] or Taiwan [36] Int. J. Environ. Res. Public Health 2010, 7                 
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cannot, or only with severe limitations, be transferred to Germany. Technology availability and costs 
may also vary between urban and suburban areas in a country, which can hamper the transferability of 
the results by Robertson et al. [48-50]. 
Absolute and relative prices can differ between countries and over time. Both prices can have an 
important impact on cost-effectiveness of technologies or treatment decisions. For physical activity 
programmes,  the  absolute  and  relative  prices  of  programme  costs  can  also  be  important  for 
transferability.  Programme  costs  were  considered  in  14  studies,  but  not  all  of  them  separated 
quantification and valuation of resource use [36-45,48-51]. Information on physical units is important 
for the transferability because prices such as the wage of a trainer can differ from one country to 
another. However, this is not reported properly in all studies. 
Practice  variation  may  influence  the  effectiveness  of  the  intervention  of  different  treatment 
practices, which can result in different outcomes. For example, Fretheim et al. described the patterns of 
antihypertensive drugs in ten countries and explored possible reasons for an inter-country variation. 
Suggested  factors  to  explain  inter-country  variation  included  reimbursement  policies,  prescribing 
patterns, traditions, opinion leaders with conflicts of interests, domestic pharmaceutical production and 
clinical practice guidelines [69]. 
Eight  reviewed  studies  were  conducted  in  general  practices  in  New  Zealand  [38,48-50],  the  
UK [42], Australia [45] or the USA [47]. Their transferability of the results could be limited because of 
inter-country  variations  in  charges,  politics  and  traditions.  The  transferability  of worksite physical 
activity programmes depends on how much an employer will benefit from reduced healthcare costs. 
Thus, the results of the Dutch intervention programme [41] may be transferable to Germany. 
The transferability of results of an intervention also depends on the population characteristics of the 
specific  target  group.  This  includes  the  prevalence  or  incidence  of  inactivity,  the  case-mix,  the  
life-expectancy of the population, the health status preferences, the compliance with and acceptance of 
the physical activity programme, and the valuation of productivity and work-loss time. 
The prevalence of physical inactivity differs between countries, e.g., Germany with 35.6% during 
the years 1990–92, UK 9.0% in 1990, USA with 14.4% in 1992, Canada with 33.0% during the years 
1981–88 and Australia with 17.5% during the years 1984–87 [70]. The prevalence of physical activity 
in Canada [37,52,53] is the most similar to the German situation. 
The impact of physical inactivity on the population’s health can be measured by use of the PAF 
(disease-specific  population  attributable  fractions)  in  the  number  of  DALYs  (disability-adjusted  
life-years) or deaths. This is the proportion of the disease burden of the population that would be 
eliminated if the current exposure to the risk factor were reduced to the feasible minimum. PAFs can 
influence savings and, therefore, the ICER of an intervention programme. WHO estimates that in the 
year 2002 the joint PAF for inactivity for Germany was about 3.2% of DALYs and 5.9% of number of 
deaths, for the Netherlands (DALYS: 2.7%; deaths: 4.5%) and for the UK (DALYS: 3.1%; deaths: 
5.5%) [71]. The differences in PAFs for inactivity are between 0.5% of the DALYs and 1.0% of the 
deaths between these three countries. Hence, the transferability of the studies from the Netherlands and 
the UK [39,41] to Germany could be given. Life-expectancy from birth of the population of Australia, 
Canada, Germany, Taiwan, New Zealand, the UK, the Netherlands and USA ranges between 80.6 
years of age (Australia) and 77.8 years of age (USA) in 2004 [72]. Therefore, the population of the 
reviewed studies have a comparable life expectancy and the results could be transferred to Germany. Int. J. Environ. Res. Public Health 2010, 7                 
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The case-mix of the target group, i.e., age, sex, race, education and other risk factors, may have a 
strong impact on the effectiveness of a physical activity programme, the participation, and the indivual 
utilisation of healthcare [73-75]. In terms of transferability, it is necessary that the target population fits 
to  the  transferred  country.  Reviewed  physical  activity  programmes  are  different  with  regards  to  
case-mix  in  terms  of  age  groups,  inclusion  and  exclusion  criteria.  For  example,  transferability  of 
studies  to  Germany could  be limited because of a very specific study population,  e.g., uninsured,  
low-income women in the USA [40], other strong inclusion criteria or an unknown target group [37]. 
The transferability of the results is limited if an intervention is only effective for a very specific target 
group, such as for people older than 65 years or men aged 60 years [43,48-50]. These results can hardly 
be generalised and transferred beyond the population under research. 
Between countries, preferences for different health states and trade-offs between lifetime and life 
quality can vary. Johnson et al. compared directly elicited valuations for EQ-5D health states between 
the US and UK general adult populations. The US mean scores were numerically higher than those for 
the  UK  for  39  health  states.  Greater  differences  in  valuations  were  present  only  in  health  states 
characterised with extreme problems [76]. Other authors compared the Finnish and US-based visual 
analogue scale valuations of the EQ-5D measure, finding that country-specific differences were not 
large and not dependent on the dimension and the level of problem [77]. There is a lack of published 
data  that  have  evaluated  and  compared  the  SF-36  health  states  and  their  preference  weights  for 
Germany, the UK and New Zealand. Four identified studies have assessed QALYs as an outcome 
parameter,  conducted  in  the  UK,  Taiwan,  New  Zealand  and  as  a  sensitivity  analysis  also  by  
Lindren  et  al.  in  Sweden  [36,39,43,44]. The QALYs of two studies reviewed from UK and New 
Zealand are derived by using the SF-36 as it is used in Germany. These results of the different health 
states evaluated could be transferred due to the assumption of minimal differences in health states and 
quality of life [78-80]. 
Acceptance of physical activity programmes is an important precondition for the success of such a 
programme. Culture and religion are typical parameters that might influence acceptance. As some 
religions, for example, advocate the separation of men and women, a joint physical exercise for women 
and men would not be accepted in those countries. Fourteen of the reviewed studies were conducted in 
Western countries in their study population. Therefore, the transferability to Germany could be given. 
Compliance and participation rate of a physical exercise programme influence the effectiveness. 
Hence, a better compliance could affect outcomes if the intervention is suitable for the target group. 
This important dimension was fully announced by 12 studies [36,37,39-43,45,47-50]. Differences in 
compliance with physical activity between countries were not published. All studies that mentioned 
compliance will be positively assessed with regard to transferability. 
In terms of productivity and work-loss time, all seven countries are high-income countries [81] for 
which no relevant differences would be assumed. 
In summary, none of the reviewed study results can be transferred without limitations. According to 
the criteria discussed above, five studies and their results cannot be transferred to the German setting at 
all because of, for example, unspecific outcomes, no declaration of physical units and price year, a very 
specific  setting  or  perspective  such  as  the  viewpoint  of  a  US  company  or  a  very  specific  target  
group  [37,40,42,47,51].  One  study  met  half  of  the  eligibility  criteria  but  the  results  cannot  be 
transferred because of missing physical units, no price year and a company perspective  [41]. Five Int. J. Environ. Res. Public Health 2010, 7                 
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studies can only be transferred to Germany with limitations, e.g., limitations due to different healthcare 
systems or because of missing price year [36,38,39,44,45]. The study of Elley et al. provides only weak 
evidence  for  its  efficacy  results  because  of  various  sources  of  bias  as,  for  example,  it  cannot  be 
excluded  that  only  motivated  people  participated  in  the  study  [38].  Another  study  that  could  be 
transferred to Germany with moderate limitations is the physical activity programme of Munro et al., 
which was conducted in a community of the UK from a health service perspective [39]. The three 
studies  by  Robertson  et  al.  investigating  programmes  to  prevent  falls  in  elderly  people  might  be 
transferable with minor limitations. Differences in health care system might affect costs, e.g., in terms 
of healthcare savings due to reduced utilisation of healthcare services. Furthermore the results can only 
be transferred to a similar type of service population [48-50]. The study by Lindgren et al. meets most 
of the criteria, and thus seems transferable with minor limitations. A positive aspect is that the model is 
based on the Framingham risk scores calculated for Germany and the UK. However, the intervention is 
not described properly, only includes men aged 60 years and does not allow for conclusions regarding 
other  study  populations  [43].  Appendix  Table  3  provides  a  summary  of  the  major  limitations  
affecting transferability. 
4. Discussion 
In summary, 15 economic evaluations of primary preventive physical activity programmes from 
seven different countries (New Zealand, the USA, UK, Canada, Australia, Taiwan, the Netherlands) 
were identified that met eligibility criteria. Most of the identified studies conclude that the investigated 
intervention provides good value for money compared with alternatives or even cost saving. However, 
it  is  not  possible  to  rank  these  results.  It  is  difficult  to  asses  to  what  extent  the  variation  in  
cost-effectiveness is due to different methods of valuing costs or cost savings and/or health outcomes. 
This  review  shows a lack of standardisation of what  constitutes either costs or outcomes  in  such 
interventions and their evaluations; the inclusion of cost variables such as for gym, equipment, salaries 
of site health personnel are not standardised. The level of evidence on effectiveness depends on the 
study design, with the highest ranking being randomised clinical trials, which were conducted in 13 
studies (including cluster randomised trials). According to the above stated criteria, seven studies were 
of high and eight studies of moderate clinical evidence. In total, seven studies provided high economic 
evidence  in  their  special  country  context,  with  at  least  80%  of  the  quality  criteria  fulfilled.  Six 
economic evaluations were deemed moderate and two poor in methodological quality with only half of 
the quality criteria met. Only four studies seem to be transferable with minor limitations, five studies 
may be transferable with moderate limitations and six studies are not transferable due to substantial 
constraints regarding the criteria of Welte et al. [35]. Those were, in general, poor in the ‘population 
characteristics’  and  ‘methodological  characteristics’.  Very  few  details  were  given  about  the  study 
sample and about the calculation of the cost results. It would be of utmost importance that authors 
present costs and physical units separately, provide the sources of the resource consumption data or 
unit prices, methods of valuation, including price year and discount rate, the perspective chosen and 
thus cost components included. These aspects were not stated in several studies, although they are 
essential for the economic evidence [32] and transferability of study results [35]. Int. J. Environ. Res. Public Health 2010, 7                 
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 The main limitations of this review are that the collection of publications was limited to those 
referenced  in  given  databases.  Only  English  and  German  papers  were  included,  missing  all 
publications in other languages. The selection and analysis of the studies was conducted by only two 
researchers, leaving room for a possible bias, however the rate of concordance was around 90%. The 
costs of the studies were adjusted to Euros (2008) to show better comparability between the studies. 
But this explanatory power is limited because country-specific healthcare systems, their prices and 
charges, etc. were not taken into account in the calculation. In order to generalise the results to other 
settings,  regions  or  countries,  an  economic  re-analysis  is  recommended  to  account  for  different 
inactivity  prevalence  or  incidence,  healthcare  systems,  absolute  and  relative  prices,  etc.  However, 
comprehensive and standardised checklists were used to establish the methodology, quality of evidence 
and  transferability  of  each  study.  The  level  of  overall  economic  evidence  was  assessed  using  a  
non-weighted quantitative score. The use of scales with summary scores to distinguish high and low 
quality studies is, however, highly controversial [82]. In this study, the score values are only used as 
support  to  get  an  estimate  for  overall  quality.  Nonetheless,  the focus  is  clearly on the qualitative 
analysis of the single quality criteria, as this score does not account for the importance of the single 
criteria in a special context by weights. 
In general, intervention programmes and the time horizons of their subsequent evaluations must be 
of sufficient duration to substantiate clinical effectiveness and/or cost outcomes. Results from a review 
by Pelletier suggest that a programme should be maintained for a minimum of around 3–9 months to 
show results in health risk reductions and/or cost-effectiveness [83]. Clearly, programme effects are 
more likely to  be maintained if the programme is  continued for a longer duration. Ideally, health 
promotion  should  be  supported  by  decision-makers,  politicians  and  stakeholders,  so  that  they  can 
become part of the setting or organisation. Physical exercise programmes of well-executed large-scale 
corporate initiatives can show that when such programmes are well integrated into the human resource 
strategy of a setting or organisation and accepted as the norm, they are likely to be well implemented 
and  effective.  Essentially,  the  time  horizon  of  the  evaluation  should  be  long  enough  to  catch  all 
relevant  differences  in  the  consequences  and  costs  of  the  alternatives  compared  [70].  Another 
limitation is the seasonal bias if a physical activity programme lasts less than one year. Levels of 
physical activity vary with seasonality and the subsequent effect of bad or extreme weather has been 
identified as a barrier to participation in physical exercise among various populations [84]. Weather 
accounts for nearly half of variance in measured physical activity programmes [85], and, therefore, in 
the  effectiveness  because  of  a  better  or  worse  participation  rate  and  compliance.  The  pattern  of 
seasonality also affects the kind of physical activity. Unusually hot, cold or wet weather conditions 
during the conduct of a programme should be appropriately be taken into account in the evaluation to 
ensure the generalisability of the results of the intervention. This holds especially for programmes of 
short duration. Also, seasonal effects could affect the sickness rate of people; in general, people have 
increased risks of getting ill in wintertime. Proper et al. measured sick leave days from work as an 
outcome of their exercise intervention. This intervention took place from May 2000 to January 2001 
and  left  out  the  time from  February to  April with  an above-average susceptibility particularly for 
airway  diseases.  Therefore,  the  seasonal  effect  could  affect  the  costs  and  effectiveness  of  this 
intervention [41]. Int. J. Environ. Res. Public Health 2010, 7                 
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Extending the length of the follow-up time seems to be associated with a positive clinical and cost 
outcome  impact  of  the  intervention  [37,48-50,53,86].  Such  outcomes  underscore  the  necessity  of  
long-term  support  to  sustain  short-term  changes  in  risk  factors.  Some  studies  included  multiple 
sequential  follow-up  assessments  in  different  time  horizons  [37,42,47,51].  These  studies  help  to 
evaluate the extent to which early intervention effects endure over time. 
Contrary to the clear recommendations in most guidelines, some studies neither discounted future 
costs nor effects even in cases of rather long time horizons, i.e., up to 12 years [37]. 
In primary prevention, the promotion of physical activity is directed towards inactive people. It is a 
challenge to motivate these people to do physical exercise, particularly when they feel healthy. A 
person who likes sport is easy to enthuse for a new kind of physical activity. Therefore, the success of a 
primary prevention physical activity intervention mainly depends on the recruitment and response rate 
of the appropriate study population. 
Although all studies measured the programme costs, decision-makers confronted with the question 
of whether or not to transfer and implement the programme need to be fully informed about the cost 
items included in the total programme costs. Even if most studies did provide a detailed description of 
the costs of the intervention programme in their country currency, data on the underlying quantities of 
resources  used  and  the  price  year  were  often  not  displayed  in  the  publications,  thus  making 
transferability of economic results difficult. In addition, outcomes of physical activity interventions 
were selected in accordance to the respective intervention aim. Yet, for direct comparisons of the 
different types of physical activity interventions similar outcomes would be important. For example, 
only three studies  used QALYs as  an outcome variable, the other studies  could  not  be compared 
regarding their outcomes. Main areas of uncertainty were often not considered in the studies. The 
sensitivity analyses were often of low quality, e.g., insufficient explanation was given for the range of 
parameters chosen for the sensitivity analysis, leaving the impression of arbitrariness. 
5. Conclusions 
This  review targets  clinicians,  behavioural  scientists,  researchers working in the field of public 
health, and decision-makers. It may, to some degree, show the difficulties of economic evaluation in 
the area of primary prevention. It aims to provide useful information for decision-makers, asking which 
study has the best methodological quality and which intervention can be transferred to another country. 
In sum, most of the studies reviewed conclude that the investigated programme provides good value 
for money compared with alternatives. However, it is not possible to compare these results directly. 
Some  of  the  studies  indicate  that  different  approaches  for  increasing  physical  activity  levels  are 
advisable in different segments of the adult population. 
The review has shown the differences in economic evaluation methods including costing, outcomes 
and results and that the overall quality of the economic evaluations varied widely across and within 
each category. Though several studies proved high economic and clinical evidence, the results of most 
of them are not transferable to a different country or setting without limitations. The main implication 
of this study is that high methodological quality and explicit reporting are important to assess potential 
generalisability  or  transferability  of  the  results  of  the  economic  evaluations  of  physical  exercise 
interventions.  Authors  of  studies  should  explore  through  sensitivity  analysis  whether  their  results Int. J. Environ. Res. Public Health 2010, 7                 
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would apply in a different patient population or a different healthcare setting. The transferability can 
only  be  explored  in  detail  if  future  studies  comply  more  closely  with  the  guidelines  and 
recommendations  for  methodological  standards  of  economic  evaluations  [32,35,87].  Hence,  a 
considerable  reduction  in  the  variability  of  methods  used  in  the  evaluation  of  primary  prevention 
programmes  could  be  achieved  if  the  authors  reported  the  necessary  data,  like  country-specific 
prevalence/incidence  data,  prices,  years,  physical  units,  treatment  patterns,  perspectives,  and 
characteristics of settings and populations. Therefore, studies should ensure that all costs and outcomes 
are  included  and  that  resources  are  described  and  valued  appropriately.  This  will  enhance  the 
comparability and generalisability of the outcomes and cost estimates of an intervention programme as 
transferability of economic evaluations is of growing importance to decision-makers due to scarce 
resources in the healthcare system. 
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Appendix 
 
Figure  1.  Flow  of  information  through  the  different  phases  of  the  systematic  review 
according to PRISMA guidelines [23]. 
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Table 2. Evaluation of economic evidence according to CHEC-List by Evers et al. (2005)
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Dzator et al. 
(2004) [51] 
0,5  1,0  1,0  1,0  0,5  0,0  0,5  0,0  0,5  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  0,0  0,74 
Elley et al. (2004) 
[38] 
1,0  0,5  1,0  1,0  0,5  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  0,5  1,0  0,0  0,87 
Finkelstein et al. 
(2002) [40] 
1,0  0,5  1,0  1,0  0,5  0,0  0,5  0,0  0,5  1,0  0,5  1,0  1,0  1,0  1,0  1,0  0,5  1,0  1,0  0,74 
Robertson et al. 
(2001a) [50] 
1,0  1,0  1,0  1,0  0,5  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  0,0  0,92 
Robertson et al. 
(2001b) [49] 
1,0  1,0  1,0  1,0  0,5  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  0,5  1,0  0,0  0,89 
Robertson et al. 
(2001c) [48] 
1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  1,0  0,0  1,0  1,0  1,0  1,0  0,0  0,89 
Stevens et al. 
(1998) [42] 
1,0  1,0  1,0  0,5  0,0  0,0  0,0  0,0  0,0  1,0  1,0  1,0  0,0  1,0  1,0  1,0  1,0  1,0  0,0  0,61 
The Writing 
Group (2001) [47] 
1,0  1,0  0,5  0,0  1,0  0,0  0,0  0,0  0,0  1,0  1,0  1,0  1,0  0,0  0,0  0,5  0,0  1,0  0,0  0,47 
Proper et al. 
(2004) [41]  
1,0  1,0  0,5  1,0  0,0  0,5  1,0  0,0  0,5  1,0  1,0  0,5  1,0  1,0  1,0  1,0  1,0  1,0  0,0  0,74 
Shepard (1992) 
[37] 
0,5  0,5  0,5  1,0  1,0  0,0  0,5  0,5  0,5  1,0  0,5  0,5  0,0  0,0  0,0  1,0  0,5  0,0  1,0  0,50 Int. J. Environ. Res. Public Health 2010, 7                 
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Chen et al. (2008) 
[36] 
1,0  1,0  1,0  1,0  0,0  0,0  1,0  0,0  0,5  1,0  1,0  1,0  1,0  1,0  0,0  1,0  0,5  1,0  1,0  0,74 
Dalziel K, Segal L 
(2006) [44] 
1,0  0,5  1,0  1,0  1,0  0,5  0,5  0,5  0,5  1,0  1,0  1,0  1,0  1,0  1,0  0,5  1,0  1,0  0,0  0,79 
Lindgren P et al. 
(2003) [43] 
1,0  1,0  1,0  1,0  1,0  1,0  0,5  0,5  0,5  1,0  1,0  1,0  1,0  1,0  1,0  0,5  0,5  1,0  0,0  0,82 
Munro et al. 
(2004) [39] 
1,0  1,0  1,0  1,0  1,0  0,5  1,0  1,0  1,0  1,0  1,0  1,0  1,0  0,0  1,0  1,0  0,5  1,0  0,0  0,84 
Sims J et al. (2004) 
[45] 
0,5  1,0  1,0  1,0  1,0  0,5  1,0  0,5  0,5  1,0  1,0  1,0  1,0  1,0  1,0  1,0  0,5  1,0  0,0  0,82 
1 Asessment: Yes = 1; No = 0; Unclear= 0,5; Economic evidence grade: 0–0.50 = low; >0.50–0.80= moderate/limited; >0.80–1= high; 
2 <1year = 0; 1–<2 years = 0.5; >2 years = 1; 
3 The valuation of the reviewed studies without discounting was calculated with 1 if the evaluation period was less than 18 months and 0 if the time horizon was more than 18 
months.  
 
Table 3. Limitations of transferability of economic evaluation results according to Welte et al. (2004)
 1 [35]. 
Author (year)  Main Limitations with respect to transferability 
Dzator et al. 
(2004) [51] 
duration of the intervention relatively short (16 weeks); higher economic status was over-represented in the study (potential bias); responders more motivated than non responders 
(selection bias); perspective not stated; only costs were discounted; price year not stated; high clinical and moderate economic evidence 
Elley et al. (2004) 
[38] 
control group may have taken part in exercise trial (potential bias); 1/3 of eligible participants did not participate (selection bias); large 95%CIs and imprecision around changes in 
major offset costs, especially healthcare utilisation costs and productivity costs (an overall cost-effectiveness from societal perspective could not be calculated); only costs were 
discounted; moderate clinical and high economic evidence 
Finkelstein et al. 
(2002) [40] 
baseline comparability of two groups not discussed; uninsured, low income women (US specific sample); no control group with no intervention; no discussion about women not 
taking part in interventions; no sensitivity analysis; perspective not stated; costs for single unit are not stated; price year not stated; only effects discounted; moderate clinical and 
moderate economic evidence 
Robertson et al. 
(2001a) [50] 
district nurse (potential instructor bias); only cost-saving for people older than 80 years; costs could be different in an urban area (e.g., less transport costs); high clinical and high 
economic evidence Int. J. Environ. Res. Public Health 2010, 7                 
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Robertson et al. 
(2001b) [49] 
general practice nurse (potential instructor bias); costs could be different in an urban area (e.g., less transport costs); no randomisation; moderate clinical and high economic  
evidence 
Robertson et al. 
(2001c) [48] 
research physiotherapist (potential instructor bias); costs could be different in an urban area (e.g., less transport costs); no discounting; high clinical and high economic evidence  
Stevens et al. 
(1998) [42] 
perspective not stated; no explanation for choice of comparator; no data on effectiveness; exercise development officer (potential therapist bias); short intervention time (10 
weeks); unit costs could be halved with a better recruitment strategy; ICER not stated; perspective not stated; physical units not stated; no discount rate; price year not stated; 
valuation of the costs not mentioned; high clinical and moderate economic evidence 
The Writing Group 
(2001) [47] 
only effects are differentiated; not significantly effective for men; perspective not stated; discount rate not stated; physical units not stated; sensitivity analysis not stated; cost 
measurement and valuation not stated; high clinical and low economic evidence 
Proper et al. (2004) 
[41] 
large CIs of CE-Ratios (not statistical significant); health care costs only accountable by municipal service; underpowered trial= 94-167; potential other benefits excluded like 
employer turnover, productivity, commitment; CBA is a CEA (no monetary valuing of the benefits); price year not stated; physical units not stated; high clinical and moderate 
economic evidence  
Shepard (1992) 
[37] 
costs not stated explicitly; study years not stated appropriately; no randomisation of the study population; not all items of programme costs calculated; CEA and CBA are not 
explained adequately; no further description of the target population; ICER not stated; perspective not stated; no discounting; physical units not clearly stated; sensitivity analysis 
not stated; moderate clinical and low economic evidence 
Chen et al. (2008) 
[36] 
perspective not stated; physical units not stated; no sensitivity analyses; short time horizon; valuation of utilisation not stated; only programme costs included; high clinical and 
moderate economic evidence 
Lindgren P et al. 
(2003) [43] 
only 60 year old men - transferability to other ages unclear; Markov Model uses risk factors taken from Framingham (calculated for UK and Germany); only Human Capital 
approach; Physical activity programme not described; high clinical and high economic evidence  
Dalziel K, Segal L 
(2006) [44] 
based on many assumptions; wide range of ICER; short follow up period in the primary clinical trial (Elley et al. 2004); moderate clinical and moderate to high economic evidence 
Munro et al. 
(2004) [39] 
SF-36 non responders were assumed having no health benefit; benefit by participants in exercise programmes greater than the suggests (potential selection bias); exclusion of the 
top 20% (selection bias); participation rate and levels of missing data are correlated; low recruitment rate; follow-up period too short for mortality and admission rates; no 
discounting; moderate clinical and high economic evidence 
Sims J et al. (2004) 
[45] 
method of discounting not explained; model and costs not described in detail; no indirect costs; percentage of patients to become active assumed; moderate clinical and high 
economic evidence 
Abbreviations: CBA: Cost-benefit analysis; CE: Cost-effectiveness; CEA: Cost-effectiveness analysis; ICER: Incremental cost-effectiveness ratio; CI: Confidence interval; UK: United Kingdom; US: 
United States. 
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